MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-08-0009083
Kausikh Therapeutics Private Limited - pharma in Gerugambakkam, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹60.69 Cr
▲ 8% YoY
Net profit · FY 2025
₹53.33 Lakh
Net margin 0.9%
EBITDA · FY 2025
₹4.17 Cr
EBITDA margin 6.9%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹5 Cr
Issued & subscribed
Open charges
₹56.48 Cr
Satisfied ₹7.83 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
161
Provident fund records
About Kausikh Therapeutics Private Limited
Data last updated:
Kausikh Therapeutics Private Limited is a private limited company based in Gerugambakkam, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 April 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24232TN2000PTC044776. Its GSTIN is 33AABCK5176D1ZT (Tamil Nadu).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹5 Cr. It is led by directors including Vaidhyanathen Neelakantan (Managing Director) and Vaidhyanathan Ramasubrahmanian.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No. 6 & 7 Door No. 728 Kakkanji Cross Street Paraniputhur Road, Gerugambakkam, Tamil Nadu, India – 600122.
As per the financials filed for FY 2025, the company reported a revenue of ₹60.69 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹53.33 Lakh (net margin 0.9%) and EBITDA of ₹4.17 Cr (EBITDA margin 6.9%). Revenue has grown at a compounded annual rate (CAGR) of 14% over five years.
The company has about 161 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Kausikh and Kausikh Therapeutics. As per MCA filings, the company has open charges of ₹56.48 Cr and satisfied charges of ₹7.83 Cr on record. Court records list 21 cases involving the company, including 2 filed by the company and 19 filed against it; 7 cases are pending.
Kausikh Therapeutics Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-08-0009083). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kausikh.co.in.
Company details
CIN U24232TN2000PTC044776
Registration Number 044776
Incorporation Date 19 April 2000
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-08-0009083
Key People
Vaidhyanathen Neelakantan Managing Director Vaidhyanathan Ramasubrahmanian Director Anantharamkrishnan Vaidhyanathen Director Recognitions & Rankings of Kausikh Therapeutics
Contact details
Kausikh Therapeutics Private Limited's registered office is in Gerugambakkam, Tamil Nadu. Its website is kausikh.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo. 6 & 7 Door No. 728 Kakkanji Cross Street Paraniputhur Road, Gerugambakkam, Tamil Nadu, India – 600122
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kausikh Therapeutics Private Limited, buy the company report.
Comprehensive company report
Kausikh Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Kausikh Therapeutics operates two associated brands: Kausikh and Kausikh Therapeutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical formulations, dosage forms, and offers contract research for global clients. | kausikh.co.in | |
| CMO with capabilities to manufacture FDFs, vitamins and mineral supplements | ktplchennai.com |
Business activity
The main business activity of Kausikh Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Kausikh Therapeutics Private Limited, buy the company report.
Financials of Kausikh Therapeutics Private Limited
FY 2024 filings availableKausikh Therapeutics Private Limited reported revenue of ₹60.69 Cr (up 8% YoY) for FY 2025.
Revenue · FY 2025
₹60.69 Cr ▲ 8%
Net profit · FY 2025
₹53.33 Lakh margin 0.9%
EBITDA · FY 2025
₹4.17 Cr margin 6.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▼ 3%
5 years · compounded
▼ 4%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 8% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.17 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹53.33 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.9% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kausikh Therapeutics Private Limited, buy the company report.
Board of directors of Kausikh Therapeutics Private Limited
Kausikh Therapeutics has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vaidhyanathen Neelakantan | Managing Director | 19 Apr 2000 | 26 Years 6 Months | Current |
| Vaidhyanathan Ramasubrahmanian Also directs: Lux Flavours India Private Limited, Ranemarg Flavours & Fragrances Private Limited, Subhikshaa Hospitals Private Limited and 1 more | Director | 19 Apr 2000 | 26 Years 6 Months | Current |
| Anantharamkrishnan Vaidhyanathen | Director | 19 Apr 2000 | 26 Years 6 Months | Current |
Peer comparison
Kausikh Therapeutics Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mars Therapeutics Private Limited | ₹60.85 Cr (FY 2025) | 25.0% | Hyderabad, Telangana, India | |||
| Yacca Lifesciences Private Limited | ₹60.81 Cr (FY 2024) | 39.0% | Roorkee, Uttarakhand, India | |||
| Kausikh Therapeutics Private Limitedthis company | ₹60.69 Cr (FY 2025) | ₹53.33 Lakh | 0.9% | 8.0% | 161 | Gerugambakkam, Tamil Nadu, India |
| Lok-Beta Pharmaceuticals (India )Private Limited | ₹60.2 Cr (FY 2024) | 40.0% | Mumbai, Maharashtra, India | |||
| Deccan Health Care Limited | ₹59.74 Cr (FY 2024) | 33.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Kausikh Therapeutics Private Limited, buy the company report.
Auditor
Kausikh Therapeutics Private Limited is audited by S Mahadevan &Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S Mahadevan &Co | FY 2024 | 001926S |
Shareholding
The shareholding of Kausikh Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kausikh Therapeutics Private Limited, buy the company report.
Charges & borrowings
Open charges
₹56.48 Cr
Satisfied charges
₹7.83 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Sep 2025 | 101180843 | Others | ₹2 Cr | Open | |
| 25 Jul 2025 | 101139243 | Others | ₹28.46 Lakh | Open | |
| 29 Feb 2020 | 100374718 | Others | ₹38.19 Cr | Open | |
| 26 Apr 2019 | 100266909 | Others | ₹16 Cr | Open | |
| 03 Feb 2014 | 10480292 | Indian Bank | ₹90 Lakh | Satisfied |
To see the full charge records of Kausikh Therapeutics Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Kausikh Therapeutics Private Limited has 21 court cases on record: 2 filed by Kausikh Therapeutics, 19 filed against it. 7 cases are pending and 14 are disposed.
Total cases
21
Filed by the company
2
Filed against the company
19
Pending
7
Disposed
14
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 16 | 16 | 6 |
| District courts | 5 | 3 | 1 |
Cases on record (5 of 21)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TAMIL NADU | Appeal | Filed against the company by M/S .Indo French Laboratories Limited, Rep by Its Director Ms.Ianthy Fernandez | Pending |
| High Court, TAMIL NADU | Original application | Filed against the company by M/S .Indo French Laboratories Limited, Rep by Its Director Ms.Ianthy Fernandez | Pending |
| High Court, TAMIL NADU | Civil suit | Filed against the company by M/S .Indo French Laboratories Limited | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company by Integrace Private Limited | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Integrace Private Limited | Pending |
To see the full case history of Kausikh Therapeutics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Kausikh Therapeutics Private Limited was last rated by Crisil on 17 Jul 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 17 Jul 2020 |
To see the full credit ratings and regulatory alerts of Kausikh Therapeutics Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kausikh Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kausikh Therapeutics Private Limited has a workforce of 161 employees on its EPFO records as of Feb 24, 2025, across 1 active EPFO establishment.
Employee count
161
Active EPFO establishments
1
Employee growth
-8%
GST
Kausikh Therapeutics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AABCK5176D1ZT | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kausikh Therapeutics Private Limited, buy the company report.
Recent activity
Kausikh Therapeutics Private Limited has 4 board changes on record since 2000: 3 appointments and 1 cessation. The latest: Lalitha Mahadevan ceased to be Director on 10 Feb 2014.
AGM
Kausikh Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101180843 was registered on 16 Sep 2025.
Charges
A charge with Others amounted to Rs. 0.28 Cr with Charge ID 101139243 was registered on 25 Jul 2025.
Charges
A charge with Others of Rs. 38.19 Cr registered on 29 Feb 2020 with Charge ID 100374718 was modified on 29 Apr 2024.
Filing
Kausikh Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Charges
A charge registered on 03 Feb 2014 via Charge ID 10480292 with Indian Bank was fully satisfied on 15 Oct 2020.
Charges
A charge with Others amounted to Rs. 38.19 Cr with Charge ID 100374718 was registered on 29 Feb 2020.
Charges
A charge with Others amounted to Rs. 16.00 Cr with Charge ID 100266909 was registered on 26 Apr 2019.
Ceased
Lalitha Mahadevan ceased to be Director.
Charges
A charge with Indian Bank amounted to Rs. 0.90 Cr with Charge ID 10480292 was registered on 03 Feb 2014.
Charges
A charge registered on 25 Mar 2010 via Charge ID 10261911 with Indian Bank was fully satisfied on 26 Jan 2014.
Charges
A charge registered on 13 Sep 2007 via Charge ID 10069508 with Hdfc Bank Limited was fully satisfied on 04 Oct 2011.
9 earlier events are in the company report.
Frequently asked questions
Kausikh Therapeutics is an active private limited company based in Gerugambakkam, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 April 2000 (26+ years old) and is registered under CIN U24232TN2000PTC044776.
Kausikh Therapeutics has 3 current directors:
- Vaidhyanathen Neelakantan - Managing Director
- Vaidhyanathan Ramasubrahmanian - Director
- Anantharamkrishnan Vaidhyanathen - Director
The latest financial statements of Kausikh Therapeutics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kausikh Therapeutics is 33AABCK5176D1ZT, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Kausikh Therapeutics is U24232TN2000PTC044776. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kausikh Therapeutics has 21 court cases on record: 2 filed by the company and 19 filed against it. 7 are pending. Most are in the high courts.
Kausikh Therapeutics was incorporated on 19 April 2000, making it 26+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Kausikh Therapeutics by revenue are Mars Therapeutics Private Limited, Yacca Lifesciences Private Limited, Lok-Beta Pharmaceuticals (India )Private Limited, Deccan Health Care Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Lalitha Mahadevan ceased to be Director on 10 Feb 2014. Anantharamkrishnan Vaidhyanathen was appointed as Director on 19 Apr 2000. Vaidhyanathan Ramasubrahmanian was appointed as Director on 19 Apr 2000. Kausikh Therapeutics has 4 board changes on record in total.
Yes, Kausikh Therapeutics is registered as a small enterprise under Udyam registration (number: UDYAM-TN-08-0009083).
Kausikh Therapeutics can be reached through the website kausikh.co.in. Its registered office is in Gerugambakkam, Tamil Nadu, India.